Literature DB >> 16684928

Pituitary tumour pathogenesis.

Anthony P Heaney1.   

Abstract

Pituitary adenomas are the most common tumours in the central nervous system, make up approximately 10% of all primary intracerebral tumours [1] and are found incidentally in 3-27% of autopsies [2]. The predisposition to tumour formation of the highly specialized cellular phenotypes that characterize the anterior pituitary is unexplained, but it is tempting to speculate that the same hormones, growth factors and cytokines derived from intra- and extra-pituitary sites that maintain tight hypothalamic pituitary control may also contribute to pituicyte transformation. The interplay between genetic and humoural factors to promote cellular transformation is exemplified in pituitary tumorigenesis and is discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684928     DOI: 10.1093/bmb/ldh062

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  10 in total

1.  MicroRNAs: a light into the "black box" of neuropediatric diseases?

Authors:  Ahmed Omran; Dalia Elimam; Sherien Shalaby; Jing Peng; Fei Yin
Journal:  Neuromolecular Med       Date:  2012-07-19       Impact factor: 3.843

2.  Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.

Authors:  Henriett Butz; Kinga Németh; Dóra Czenke; István Likó; Sándor Czirják; Vladimir Zivkovic; Kornélia Baghy; Márta Korbonits; Ilona Kovalszky; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

Review 3.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

4.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

5.  Effect of estrogen on the blood supply of pituitary autografts in rats.

Authors:  Matilde Lombardero; Andres Quintanar-Stephano; Sergio Vidal; Eva Horvath; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

6.  Expression of MSX1 in human normal pituitaries and pituitary adenomas.

Authors:  Yoshihito Mizokami; Noboru Egashira; Susumu Takekoshi; Johbu Itoh; Yoshiko Itoh; Robert Yoshiyuki Osamura; Mitsunori Matsumae
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  Beta human chorionic gonadotropin (beta-hCG) expression in pituitary adenomas: relationship to endocrine function and tumour recurrence.

Authors:  Paul M Doyle; Waziq A Thiryayi; Abhijit Joshi; Daniel du Plessis; Tara Kearney; Kanna K Gnanalingham
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

8.  Change in the immunophenotype of a somatotroph adenoma resulting in gigantism.

Authors:  Jayesh P Thawani; Robert L Bailey; Carrie M Burns; John Y K Lee
Journal:  Surg Neurol Int       Date:  2014-10-20

9.  The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

10.  Evaluation of survivin splice variants in pituitary tumors.

Authors:  Joanna Waligórska-Stachura; Mirosław Andrusiewicz; Nadia Sawicka-Gutaj; Marta Kubiczak; Anna Jankowska; Włodzimierz Liebert; Agata Czarnywojtek; Ryszard Waśko; Al Ricardo Blanco-Gangoo; Marek Ruchała
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.